UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$446,803,817
-$112,294,706 QoQ
Shares Held
716,560
-1.0% QoQ
Ownership
0.696%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#26
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. REGN ranks #2 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $446,803,817 | 716,560 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $559,098,523 | 723,621 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $575,222,990 | 745,233 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $418,426,147 | 744,173 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $451,731,525 | 860,441 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $596,389,294 | 940,336 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $699,553,642 | 982,064 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $793,803,933 | 755,112 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $890,939,206 | 847,682 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $658,885,997 | 684,564 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $585,275,763 | 666,381 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $572,275,680 | 695,387 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $478,679,845 | 666,184 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $547,383,403 | 666,184 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $438,201,273 | 607,356 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $414,006,731 | 600,994 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $356,775,323 | 603,548 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $402,403,755 | 576,163 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $383,912,370 | 607,918 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $317,242,009 | 524,211 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $320,165,175 | 573,218 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $292,564,222 | 618,346 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $310,853,259 | 643,442 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $331,501,150 | 592,199 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $313,107,843 | 502,057 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $163,133,289 | 334,091 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||